Publikationen in Zusammenarbeit mit Forschern von Institute Catalá Oncología (11)

2011

  1. Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 108, Núm. 11, pp. 4394-4399

2010

  1. A genetic defect in exportin-5 traps precursor MicroRNAs in the nucleus of cancer cells

    Cancer Cell, Vol. 18, Núm. 4, pp. 303-315

2009

  1. A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function

    Nature Genetics, Vol. 41, Núm. 3, pp. 365-370

  2. Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies

    Cancer Research, Vol. 69, Núm. 21, pp. 8447-8454

  3. Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect

    Oncogene, Vol. 28, Núm. 6, pp. 781-791

  4. The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer

    Genome Research, Vol. 19, Núm. 3, pp. 438-451

2008

  1. A microRNA DNA methylation signature for human cancer metastasis

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, Núm. 36, pp. 13556-13561

  2. Epigenetic inactivation of the Groucho homologue gene TLE1 in hematologic malignancies

    Cancer Research, Vol. 68, Núm. 11, pp. 4116-4122

  3. Hypermethylation of the thrombospondin-1 gene is associated with poor prognosis in penile squamous cell carcinoma

    BJU International, Vol. 102, Núm. 6, pp. 747-755

2005

  1. Growth and molecular interactions between tamoxifen and trastuzumab (multiple letters)

    Clinical Cancer Research

2004

  1. Trastuzumab plus tamoxifen: Anti-proliferative and molecular interactions in breast carcinoma

    Breast Cancer Research and Treatment, Vol. 86, Núm. 2, pp. 125-137